STING1 and neoplasm: In order to determine the effect of STING agonisttreatment on circulating pro-inflammatory cytokine profiles, we evaluated plasmacytokines in tumour-bearing mice at days 1, 8, and 28 post STING agonist treatmentinitiation, using a pre-built cytokine panel representing primary mediators ofinflammation.